Library

Ziprasidone

Oral bioavailability doubles when taken with food; dosing on an empty stomach delivers only ~36% of the intended exposure, leading users to redose unnecessarily. Therapeutic QTc prolongation averages 10-20 msec, but heavy recreational doses (>160 mg/day) or IV diversion markedly increases torsade risk. IM ziprasidone reaches Cmax within 60 minutes and has a 2-5 hour half-life, making it a common ER 'trip-stopper'. Forum reports describe 60-120 mg oral as a reliable 'stimulant-comedown knockout', with sleep onset 2-4 hours after dosing. Extrapyramidal reactions (akathisia, dystonia) and very rare tardive dystonia have occurred after weeks on 80-120 mg/day regimens.

Ziprasidone molecular structure
Ziprasidone molecular structure diagram from the DrugsPRO substance library.

Also known as: Geodon, Zeldox, Zipwell

Classification

  • Chemical: Medicine
  • Psychoactive: Depressant
  • Tag: Antipsychotic
  • Tag: Benzisothiazolyl piperazine
  • Tag: Pharmaceutical
  • Tag: Second-generation antipsychotic
  • Tag: Sedative

Effects

  • Sedation
  • Somnolence
  • Akathisia
  • Restlessness
  • Akathisia Like Movement
  • Motor Impairment
  • Emotion Suppression
  • Motivation Suppression
  • Anxiety Suppression
  • Motor Control Loss
  • Cognitive Fatigue
  • Dizziness
  • Dulled Perception
  • Acuity Suppression
  • Appetite Suppression
  • Orgasm Suppression
  • Open Eye Visuals
  • Dehydration

Routes of Administration

Oral

Dosage

  • Threshold: 10 mg
  • Light: 10 mg - 40 mg
  • Common: 40 mg - 80 mg
  • Strong: 80 mg - 120 mg
  • Heavy: 120+ mg

Duration

  • Onset: 1-3 h
  • Comeup: 1-2 h
  • Peak: 3-6 h
  • Offset: 6-10 h
  • After Effects: 10-24 h
  • Total Duration: 6-12 h

Intramuscular

Dosage

  • Threshold: 5 mg
  • Light: 5 mg - 10 mg
  • Common: 10 mg - 20 mg
  • Strong: 20 mg - 40 mg
  • Heavy: 40+ mg

Duration

  • Onset: 0.25-0.5 h
  • Comeup: 0.5-1 h
  • Peak: 0.5-1.5 h
  • Offset: 2-4 h
  • After Effects: 6-24 h
  • Total Duration: 4-10 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

Ziprasidone - DrugsPRO substance guide

Ziprasidone: Oral bioavailability doubles when taken with food; dosing on an empty stomach delivers only ~36% of the intended exposure, leading users to redose unnecessarily. Therapeutic QTc prolongation averages 10-20 msec, but heavy recreational doses (>160 mg/day) or IV diversion markedly increas

Get to know drugs.

Related pages